Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 434

1.

An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.

Salhab M, Canelo R.

J Cancer Res Ther. 2011 Oct-Dec;7(4):463-75. doi: 10.4103/0973-1482.92023. Review.

2.

Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.

Tiong L, Maddern GJ.

Br J Surg. 2011 Sep;98(9):1210-24. doi: 10.1002/bjs.7669. Epub 2011 Jul 15. Review.

PMID:
21766289
3.

Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.

Wang W, Shi J, Xie WF.

Liver Int. 2010 May;30(5):741-9. doi: 10.1111/j.1478-3231.2010.02221.x. Epub 2010 Mar 18.

PMID:
20331507
4.

Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.

Choi JY.

Oncology. 2011;81 Suppl 1:141-7. doi: 10.1159/000333277. Epub 2011 Dec 22.

PMID:
22212948
5.

Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.

Bouza C, López-Cuadrado T, Alcázar R, Saz-Parkinson Z, Amate JM.

BMC Gastroenterol. 2009 May 11;9:31. doi: 10.1186/1471-230X-9-31. Review.

6.

Updated treatment approach to hepatocellular carcinoma.

Llovet JM.

J Gastroenterol. 2005 Mar;40(3):225-35. Review.

PMID:
15830281
7.

Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.

Mahnken AH, Bruners P, Günther RW.

Dig Dis. 2009;27(2):148-56. doi: 10.1159/000218347. Epub 2009 Jun 22. Review.

PMID:
19546553
8.

Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.

Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.

J Gastroenterol Hepatol. 2008 Mar;23(3):482-90. Epub 2007 Dec 13.

PMID:
18086115
9.

Radio frequency ablation for primary liver cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(8):1-50. Epub 2004 Jun 1.

11.

Multimodal approaches to the treatment of hepatocellular carcinoma.

Cabibbo G, Latteri F, Antonucci M, Craxì A.

Nat Clin Pract Gastroenterol Hepatol. 2009 Mar;6(3):159-69. doi: 10.1038/ncpgasthep1357. Epub 2009 Feb 3. Review.

PMID:
19190599
12.

Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.

Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H.

Eur J Gastroenterol Hepatol. 2013 Feb;25(2):187-94. doi: 10.1097/MEG.0b013e32835a0a07.

PMID:
23134976
13.

[Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].

Allgaier HP, Rossi S, Deibert P, Zuber I, Hering M, Blum HE.

Praxis (Bern 1994). 2000 Jun 15;89(24):1056-60. Review. German.

PMID:
10902462
14.

Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials.

Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M.

Am J Gastroenterol. 2009 Feb;104(2):514-24. doi: 10.1038/ajg.2008.80. Epub 2009 Jan 13. Review.

PMID:
19174803
15.

[Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].

Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.

Korean J Hepatol. 2009 Dec;15(4):474-85. doi: 10.3350/kjhep.2009.15.4.474. Korean.

16.

TACE combined with PEI versus TACE alone in the treatment of HCC: a meta-analysis.

Wang N, Guan Q, Wang K, Zhu B, Yuan W, Zhao P, Wang X, Zhao Y.

Med Oncol. 2011 Dec;28(4):1038-43. doi: 10.1007/s12032-010-9620-2. Epub 2010 Jul 15.

PMID:
20632218
17.

Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?

Meza-Junco J, Montano-Loza AJ, Liu DM, Sawyer MB, Bain VG, Ma M, Owen R.

Cancer Treat Rev. 2012 Feb;38(1):54-62. doi: 10.1016/j.ctrv.2011.05.002. Epub 2011 Jul 2. Review.

PMID:
21726960
18.

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Poon RT, Fan ST, Tsang FH, Wong J.

Ann Surg. 2002 Apr;235(4):466-86. Review.

19.

Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis.

Liao M, Huang J, Zhang T, Wu H.

PLoS One. 2013 Jul 3;8(7):e68453. doi: 10.1371/journal.pone.0068453. Print 2013.

20.

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Cho YK, Kim JK, Kim MY, Rhim H, Han JK.

Hepatology. 2009 Feb;49(2):453-9. doi: 10.1002/hep.22648. Review.

PMID:
19065676
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk